Skip to content

MCK

McKesson Corporation

Revenue by segment

FY2026, ended Mar 31, 2026

Earlier:

Segments by fiscal year

Segments by fiscal year
Line, in USDFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014FY2013FY2012FY2011FY2010
North American Pharmaceutical336.7B304.5B261.4B——————————————
Oncology & Multispecialty48.4B36.9B30.5B——————————————
Medical-Surgical Solutions11.5B11.4B11.3B11.1B11.6B10.1B8.3B7.6B6.6B6.2B———————
Prescription Technology Solutions5.81B5.22B4.77B4.39B3.86B2.89B2.71B2.49B—————————
Other1.0B1.1B1.0B—————11.8B12.2B———————
———261.2B248.5B225.2B220.0B204.2B189.9B180.1B190.9B179.0B137.4B122.2B122.3B112.1B108.7B
Total403.4B359.1B309.0B276.7B264.0B238.2B231.1B214.3B208.4B198.5B190.9B179.0B137.4B122.2B122.3B112.1B108.7B